MF
IONS icon

Magnetar Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Magnetar Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23,652
Closed -$845K – 555
2023
Q1 		$845K Sell
23,652
-10,945
-32% -$411K 0.02% 405
2022
Q4 		$1.31M Buy
+34,597
New +$1.46M 0.02% 481
2021
Q2 		– Sell
-7,865
Closed -$354K – 1287
2021
Q1 		$354K Sell
7,865
-14,174
-64% -$791K ﹤0.01% 894
2020
Q4 		$1.25M Buy
+22,039
New +$1.1M 0.02% 428

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Magnetar Financial's IONS Position: Q2 2023 in Review

Magnetar Financial sold out of Ionis Pharmaceuticals (IONS) in Q2 2023, closing a stake of 23,652 shares — an estimated $845K sold.

Magnetar Financial first reported a position in IONS in Q4 2020 and held it in 4 quarters. The position peaked at $1.31M in Q4 2022. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

  • Magnetar Financial reported no remaining Ionis Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Magnetar Financial sold 23,652 Ionis Pharmaceuticals shares in Q2 2023, an estimated $845K.
  • Magnetar Financial first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Magnetar Financial's Ionis Pharmaceuticals position peaked at $1.31M in Q4 2022.
  • 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on Magnetar Financial's 13F filing for Q2 2023, filed 11 Aug 2023.